YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer scraps planned weight loss pill

Posted online

Pfizer is stopping development of a new daily weight loss pill.

A patient in the drug trial reportedly experienced a liver injury.

"While we are disappointed to discontinue the development of danuglipron, we remain committed to evaluating and advancing promising programs in an effort to bring innovative new medicines to patients," said Dr. Chris Boshoff, Pfizer's chief scientific officer.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences